All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

Pemafibrate

CAS number:848259-27-8    molecular formula:C28H30N2O6

overview

compound introduction

Pemafibrate is an highly potent and selective peroxisome proliferator-activated receptor alpha (PPARα) agonist (hPPAR EC50 = 1 nM/α, 1.10 μM/γ, 1,58 μM/δ by cell-based reporter assays using respective transfectants). When administered in vivo Pemafibrate is>100-fold more effective than fenofibrate in lowering triglyceride (TG) innormal rats (1 mg/kg p.o.) and in increasing HDL-cholesterol (HDL-C) in humanapoA-I (h-apoA-I) transgenic mice (3 mg/kg p.o.). Compared to other fibrates, pemafibrate′s distinct Y-shaped structure aids in stronger PPAR-α activation, better lipid binding, greater potency, and adaptability tostructural changes caused by binding of coactivators. Pemafibrate shows anti-inflammatory activities like lowering the levels of interleukin-6, tumor necrosis factor-α, monocyte chemoattractant protein-1, vascular cell adhesion molecule-1 (VCAM-1), macrophage marker F4/80). It also exhibits antiatherogenic effects by lowering the levels of certain factors such as plasma triglycerides(TG), TG-rich lipoproteins, and apolipoprotein C-III (apoC-III), and increases lipoprotein lipase (LPL) activity and high-density lipoprotein (HDL) levels. Pemafibrate promotes fibroblast growth factor 21 and contributes to the reduction of insulin resistance. Application: Pemafibrate may be used in research studies tostudy its effects on lipid metabolism, inflammation, and cardiovascular health. Biochem/physiol Actions: Orally active, highly potent and selective peroxisome proliferator-activated receptor alpha (PPARα) agonist with >100-fold in vivo efficacy than fenofibrate. Pemafibrate is an orally active, highly potent and selective peroxisome proliferator-activated receptor alpha (PPARα) agonist (hPPAR EC50 = 1 nM/α, 1.10 μM/γ, 1,58 μM/δ by cell-based reporter assays using respective transfectants). When administered in vivo Pemafibrate is >100-fold more effective than fenofibrate in lowering triglyceride (TG) in normal rats (1 mg/kg p.o.) and in increasing HDL-cholesterol (HDL-C) in human apoA-I (h-apoA-I) transgenic mice (3 mg/kg p.o.).

Specs

Chinese alias哌玛纤维酸 | 佩玛贝特 | (R)-2-(3-((苯并[d]恶唑-2-基(3-(4-甲氧基苯氧基)丙基)氨基)甲基)苯氧基)丁酸
English alias-
CAS number848259-27-8molecular formulaC28H30N2O6
molecular weight490.55 g/molExact mass-
PSA94.300 Ųlogp6.2

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

No safety information yet

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 0 shareMSDS